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cancers but only hypoxia-inducible factor-1a is associated with
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Correction to: British Journal of Cancer (2009) 100, 1666–1673,
doi: 10.1038/sj.bjc.6605026
Upon publication of this paper in Volume 100, the authors noticed an
error in the results section of the Abstract, where HIF-2a was expressed
incorrectly as HIF-1a. The correction is now shown below in bold.
RESULTS: MVD was higher across T- and N-stages (Po0.001)
and associated with poor survival (Hazard ratio (HR 8.7,
Po0.005) and decreased disease-free survival (HR¼4.7,
Po0.005). HIF-1a and HIF-2a were expressed in 450% of
rectal cancers (HIF-1a, 54%, 48/90; HIF-2a, 64%, 58/90). HIF-1a
positivity was associated with TNM stage (Po0.05), vascular
invasion (Po0.005), recurrence (HR¼4.5, Po0.005) and cancer-
specific mortality (HR¼5.5, Po0.002). In contrast, no asso-
ciations were demonstrated between HIF-2a and any pathological
features or outcome.
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